Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Return on Assets (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Return on Assets for 5 consecutive years, with 0.37% as the latest value for Q3 2018.

  • Quarterly Return on Assets rose 62.0% to 0.37% in Q3 2018 from the year-ago period, while the trailing twelve-month figure was 0.37% through Sep 2018, up 62.0% year-over-year, with the annual reading at 0.38% for FY2017, 12.0% up from the prior year.
  • Return on Assets hit 0.37% in Q3 2018 for Armata Pharmaceuticals, down from 0.16% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.16% in Q2 2018 to a low of 1.08% in Q2 2017.
  • Historically, Return on Assets has averaged 0.54% across 5 years, with a median of 0.47% in 2016.
  • Biggest five-year swings in Return on Assets: tumbled -61bps in 2017 and later skyrocketed 92bps in 2018.
  • Year by year, Return on Assets stood at 0.76% in 2014, then surged by 58bps to 0.32% in 2015, then crashed by -105bps to 0.65% in 2016, then rose by 29bps to 0.46% in 2017, then increased by 20bps to 0.37% in 2018.
  • Business Quant data shows Return on Assets for ARMP at 0.37% in Q3 2018, 0.16% in Q2 2018, and 0.43% in Q1 2018.